The CCNY-MSKCC Partnership for Research, Training, and Community Outreach has created cross-institutional collaboration that has emphasized research across the translational continuum, the creation of a training pipeline for attracting minority and low income students to careers in cancer research, and the establishment of community networks and resources for conducting community-based participatory research among diverse, at-risk populations. We propose two full projects that focus on translational health disparities and biomedical engineering and a pilot project which represents collaboration between computer science (CCNY) and medical physics (MSKCC) investigators. The Training Core will continue to develop training experiences for attracting minority and low income students to careers in cancer research. The Partnership Community Outreach, Research, and Education Core (PCORE) will expand services and community liaisons to promote innovative community-based participatory research designed to reduce health disparities in the New York metropolitan area and nationally. The specific objectives are to: 1) continue to develop cancer research programs in health disparities, biomedical engineering, computer science / medical imaging, cancer cell biology, and immunology along the Translational Research Continuum (Stages TO through T4);2) collaborate with diverse communities to conduct and facilitate trailblazing outreach and research to define and address cancer disparities for the large, medically underserved local and national communities;3) continue to develop and expand training opportunities in a robust translational cancer research environment to attract and retain students interested in cancer research (particularly minority and low income students);these opportunities will be enhanced by educational and training opportunities and increased mentorship and support;4) expand and integrate the personnel, resources, and environment needed for scientific collaboration across institutions.
Reduction of cancer health disparities is a high priority area requiring a multi-pronged approach that includes focused training, research, and community outreach. The CCNY-MSKCC Partnership for Research, Training, and Community Outreach provides a comprehensive approach for accomplishing these goals.
|Yeh, Yi-Chen; Nitadori, Jun-ichi; Kadota, Kyuichi et al. (2015) Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ? 3 cm: accuracy and interobserver agreement. Histopathology 66:922-38|
|Mandelblatt, Jeanne S; Jacobsen, Paul B; Ahles, Tim (2014) Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors. J Clin Oncol 32:2617-26|
|Guidry, John A; Lubetkin, Erica; Corner, Geoffrey et al. (2014) Promoting cancer prevention and control in community-based HIV/AIDS service organizations: are they ready? AIDS Educ Prev 26:43-55|
|Kadota, Kyuichi; Yeh, Yi-Chen; Sima, Camelia S et al. (2014) The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype. Mod Pathol 27:690-700|
|Eguchi, Takashi; Kadota, Kyuichi; Park, Bernard J et al. (2014) The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know. Semin Thorac Cardiovasc Surg 26:210-22|
|Dereli-Korkut, Zeynep; Akaydin, H Dogus; Ahmed, A H Rezwanuddin et al. (2014) Three dimensional microfluidic cell arrays for ex vivo drug screening with mimicked vascular flow. Anal Chem 86:2997-3004|
|Lee, Ming-Ching; Buitrago, Daniel H; Kadota, Kyuichi et al. (2014) Recent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomas. Lung Cancer Manag 3:245-253|
|Kachala, Stefan S; Bograd, Adam J; Villena-Vargas, Jonathan et al. (2014) Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma. Clin Cancer Res 20:1020-8|
|de Biasi, Andreas R; Villena-Vargas, Jonathan; Adusumilli, Prasad S (2014) Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence. Clin Cancer Res 20:5384-91|
|Lubetkin, Erica I; Zabor, Emily C; Brennessel, Debra et al. (2014) Beyond demographics: differences in patient activation across new immigrant, diverse language subgroups. J Community Health 39:40-9|
Showing the most recent 10 out of 38 publications